Thor Medical
Vær den første som følger denne virksomhed
Thor Medical is a pharmaceutical company. The company specializes in the development of antibody drugs for the treatment of hematological cancer. The greatest specialization is found in precision therapy used in the clinical phase. Other diseases that are treated are non-Hodgkin's lymphoma (NHL). The company was founded in 2009 and is headquartered in Oslo, Norway.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
Oslo Børs
TRMED
Daglig lav / høj pris
-
Markedsværdi
-
Aktieomsætning
-
Volumen
-
Finanskalender
Delårsrapport
30.08.2024
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Scatec Innovation AS | 24,5 % | 24,5 % |
Roht Invest AS | 6,9 % | 6,9 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
TRMED: Grant of restricted stock units (RSU) to the members of the board
TRMED: Issuance of shares to members of the board
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools